| Meghan Kirby, PA-C | |
|
1255 Highway 54 W, Fayetteville, GA 30214-4526 | |
| (770) 719-7000 | |
| Not Available |
| Full Name | Meghan Kirby |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 7 Years |
| Location | 1255 Highway 54 W, Fayetteville, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497278915 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Southeast Permanente Medical Group | 6204829013 | 576 |
News Archive
Neonatal brain injury is a leading cause of lifelong disability. Researchers at the George Washington University are laying the groundwork for a future where health care providers can more accurately diagnose brain injury and dysfunction in newborns with the use of an inexpensive and non-invasive diagnostic tool - electroencephalography.
Ligand Pharmaceuticals Incorporated today announced that data from a Phase I study with its selective androgen receptor modulator (SARM) LGD-4033 was featured today in a poster presentation at the 14th International Congress of Endocrinology in Kyoto, Japan. This Phase I clinical trial was the first study in humans of LGD-4033, and evaluated the safety, tolerability and pharmacokinetic profiles of the molecule in a single escalating dose, double blind, placebo-controlled study in 48 healthy volunteers.
An international team of researchers focused on the macrodomain part of the non-structural protein 3 (Nsp3) gene product that SARS-CoV-2 uses to overturn the host cell's natural antiviral response. The team provided a template that can help develop novel antivirals that are direct-acting and can combat the current pandemic.
Despite recent advances in therapy, melanoma remains the deadliest, most aggressive form of skin cancer as incidence rates continue to climb. Now, a team of melanoma scientists from The Wistar Institute and the University of Pennsylvania received a $12.5 M, five-year program project grant (P01) from the National Institutes of Health to continue trailblazing research on targeted therapies in melanoma.
Healthy adult brains are endowed with a vast number of synapses, structures that relay signals across nerve cells to enable communications, information processing and storage throughout the nervous system.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Meghan Kirby, PA-C 1922 Brookhaven Cir Ne, Brookhaven, GA 30319-3193 Ph: (850) 450-8063 | Meghan Kirby, PA-C 1255 Highway 54 W, Fayetteville, GA 30214-4526 Ph: (770) 719-7000 |
News Archive
Neonatal brain injury is a leading cause of lifelong disability. Researchers at the George Washington University are laying the groundwork for a future where health care providers can more accurately diagnose brain injury and dysfunction in newborns with the use of an inexpensive and non-invasive diagnostic tool - electroencephalography.
Ligand Pharmaceuticals Incorporated today announced that data from a Phase I study with its selective androgen receptor modulator (SARM) LGD-4033 was featured today in a poster presentation at the 14th International Congress of Endocrinology in Kyoto, Japan. This Phase I clinical trial was the first study in humans of LGD-4033, and evaluated the safety, tolerability and pharmacokinetic profiles of the molecule in a single escalating dose, double blind, placebo-controlled study in 48 healthy volunteers.
An international team of researchers focused on the macrodomain part of the non-structural protein 3 (Nsp3) gene product that SARS-CoV-2 uses to overturn the host cell's natural antiviral response. The team provided a template that can help develop novel antivirals that are direct-acting and can combat the current pandemic.
Despite recent advances in therapy, melanoma remains the deadliest, most aggressive form of skin cancer as incidence rates continue to climb. Now, a team of melanoma scientists from The Wistar Institute and the University of Pennsylvania received a $12.5 M, five-year program project grant (P01) from the National Institutes of Health to continue trailblazing research on targeted therapies in melanoma.
Healthy adult brains are endowed with a vast number of synapses, structures that relay signals across nerve cells to enable communications, information processing and storage throughout the nervous system.
› Verified 4 days ago
Cynthia M Smith, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1275 Highway 54 W Ste 201, Fayetteville, GA 30214 Phone: 770-461-3776 Fax: 770-461-3565 | |
Dr. John Edward Donohue Ii, PHYSICIAN ASSISTANT Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 427 Porter Rd, Fayetteville, GA 30215 Phone: 770-716-8206 | |
Ms. Angela Ward Cubin, CSA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1265 Highway 54 W Ste 103, Fayetteville, GA 30214 Phone: 470-514-5538 Fax: 470-514-5561 | |
Jason David Kranenburg, CSFA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1415 Highway 85 N Ste 310-147, Fayetteville, GA 30214 Phone: 937-570-2426 | |
Virginia Ann Horan, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1255 Highway 54 W, Fayetteville, GA 30214 Phone: 404-367-3014 | |
Mrs. Donna Elizabeth Hendley, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 132 Old Norton Rd Ste 200, Fayetteville, GA 30215 Phone: 678-817-1117 Fax: 678-817-0823 | |
Jessica Katherine Vernon, PA-C Physician Assistant Medicare: May Accept Medicare Assignments Practice Location: 1275 Highway 54 W Ste 201, Fayetteville, GA 30214 Phone: 770-461-3774 |